Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5270523
Max Phase: Preclinical
Molecular Formula: C47H74N16O11S3
Molecular Weight: 1135.41
Associated Items:
ID: ALA5270523
Max Phase: Preclinical
Molecular Formula: C47H74N16O11S3
Molecular Weight: 1135.41
Associated Items:
Canonical SMILES: N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)c1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@H]1CSSC[C@@H](C(N)=O)NC1=O
Standard InChI: InChI=1S/C47H74N16O11S3/c48-36(65)17-16-30(40(69)60-32(22-75)42(71)59-31(21-25-7-2-1-3-8-25)41(70)62-34-24-77-76-23-33(37(49)66)61-43(34)72)57-38(67)28(9-4-18-54-46(50)51)56-39(68)29(10-5-19-55-47(52)53)58-44(73)35-11-6-20-63(35)45(74)26-12-14-27(64)15-13-26/h12-15,25,28-35,64,75H,1-11,16-24H2,(H2,48,65)(H2,49,66)(H,56,68)(H,57,67)(H,58,73)(H,59,71)(H,60,69)(H,61,72)(H,62,70)(H4,50,51,54)(H4,52,53,55)/t28-,29-,30+,31+,32+,33+,34+,35+/m1/s1
Standard InChI Key: MVRIKDZSRRUOED-PTXZYOPASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1135.41 | Molecular Weight (Monoisotopic): 1134.4885 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Brust A, Croker DE, Colless B, Ragnarsson L, Andersson Å, Jain K, Garcia-Caraballo S, Castro J, Brierley SM, Alewood PF, Lewis RJ.. (2016) Conopeptide-Derived κ-Opioid Agonists (Conorphins): Potent, Selective, and Metabolic Stable Dynorphin A Mimetics with Antinociceptive Properties., 59 (6): [PMID:26859603] [10.1021/acs.jmedchem.5b00911] |
Source(1):